Cytogenetic alterations in ovarian clear cell carcinoma detected by comparative genomic hybridisation
2003

Genetic Changes in Ovarian Clear Cell Carcinoma

Sample size: 33 publication Evidence: moderate

Author Information

Author(s): Dent J, Hall G D, Wilkinson N, Perren T J, Richmond I, Markham A F, Murphy H, Bell S M

Primary Institution: Cancer Research UK Clinical Cancer Centre in Leeds, St James's University Hospital

Hypothesis

The study aims to characterize the genetic alterations of a cohort of pure clear cell ovarian tumors.

Conclusion

The study found frequent deletions on chromosome 9p and other chromosomal abnormalities in clear cell ovarian carcinoma.

Supporting Evidence

  • Genomic imbalances were detected in all 18 cases of OCCC examined by CGH.
  • Chromosomal losses were found more frequently than chromosomal gains.
  • Chromosome 9 was the most common site for genetic abnormalities.

Takeaway

This study looked at the DNA of women with a specific type of ovarian cancer and found common genetic changes that might help understand the disease better.

Methodology

The study used comparative genomic hybridization to analyze tumor samples from patients with clear cell ovarian carcinoma.

Limitations

The study included a limited number of cases and may not represent all clear cell ovarian carcinomas.

Participant Demographics

The median age at diagnosis was 57 years, with cases ranging from FIGO stage I to IV.

Statistical Information

Confidence Interval

95% CI 28–62

Digital Object Identifier (DOI)

10.1038/sj.bjc.6600896

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication